[HTML][HTML] Inactivated SARS-CoV-2 vaccine does not influence the profile of prothrombotic antibody nor increase the risk of thrombosis in a prospective Chinese cohort
T Liu, J Dai, Z Yang, X Yu, Y Xu, X Shi, D Wei, Z Tang… - Science bulletin, 2021 - Elsevier
The presence of antiphospholipid antibodies was shown to be associated with thrombosis in
coronavirus disease 2019 (COVID-19) patients. Recently, according to reports from several …
coronavirus disease 2019 (COVID-19) patients. Recently, according to reports from several …
[HTML][HTML] Evaluation of antiphospholipid antibodies in COVID-19 patients with coagulopathy
A Nosrati, Z Torabizadeh, LV Larijani… - Tanaffos, 2022 - ncbi.nlm.nih.gov
Background: Due to the importance of recent published studies regarding the thrombotic
events in COVID-19 patients, the purpose of this study was to evaluate the frequency of …
events in COVID-19 patients, the purpose of this study was to evaluate the frequency of …
Antiphospholipid antibodies in patient with acute lower member ischemia and pulmonary thromboembolism as a result of infection by SARS-CoV2
C Sieiro Santos, C Nogal Arias, C Moriano Morales… - Clinical …, 2020 - Springer
2, 38, urea 163 and glomerular filtrate of 20) and high levels of transaminases (ALT 231,
ASPT 149), LDH 669, CK 11.427 and D-dimer 72,016. Initial treatment with empiric antibiotic …
ASPT 149), LDH 669, CK 11.427 and D-dimer 72,016. Initial treatment with empiric antibiotic …
[HTML][HTML] Prevalence and clinical significance of antiphospholipid antibodies among hospitalized COVID-19 patients
Objective: To describe the prevalence of antiphospholipid antibodies in coronavirus disease-
19 (COVID-19) and to find potential associations between antiphospholipid antibody …
19 (COVID-19) and to find potential associations between antiphospholipid antibody …
Evaluating the relationship between antiphospholipid antibodies and COVID-19 severity
Coronavirus 2 (COVID-19) has emerged as a new global pandemic, causing severe acute
respiratory syndrome. Furthermore, the existence of antiphospholipid (APL) antibodies (Abs) …
respiratory syndrome. Furthermore, the existence of antiphospholipid (APL) antibodies (Abs) …
[HTML][HTML] Anti-cardiolipin IgG autoantibodies associate with circulating extracellular DNA in severe COVID-19
D Bertin, A Brodovitch, A Lopez, R Arcani… - Scientific reports, 2022 - nature.com
Whereas the detection of antiphospholipid autoantibodies (aPL) in COVID-19 is of
increasing interest, their role is still unclear. We analyzed a large aPL panel in 157 patients …
increasing interest, their role is still unclear. We analyzed a large aPL panel in 157 patients …
[HTML][HTML] Longitudinal analysis of antiphospholipid antibody dynamics after infection with SARS-CoV-2 or vaccination with BNT162b2
M Ogrič, P Žigon, S Sodin-Semrl… - International Journal of …, 2022 - mdpi.com
Antiphospholipid antibodies (aPL) comprise a group of autoantibodies that reflect
prothrombotic risk in antiphospholipid syndrome (APS) but may also be present in a small …
prothrombotic risk in antiphospholipid syndrome (APS) but may also be present in a small …
[HTML][HTML] The role of antiphospholipid antibodies in COVID-19
M Stelzer, J Henes, S Saur - Current Rheumatology Reports, 2021 - Springer
Abstract Purpose of the Review Elevated levels of anti-phospholipid (aPL) antibodies are
the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are …
the most important criterion in the diagnosis of anti-phospholipid syndrome (APS) and are …
[HTML][HTML] Antiphospholipid antibodies and vitamin D deficiency in COVID-19 infection with and without venous or arterial thrombosis: A pilot case-control study
R Shah, YN Mohammed, TJ Koehler, J Kaur, M Toufeili… - Plos one, 2022 - journals.plos.org
Background Coronavirus disease-2019 (COVID-19) is associated with thromboembolism.
Antiphospholipid antibody (APLa) formation is one of the mechanisms. Vitamin D deficiency …
Antiphospholipid antibody (APLa) formation is one of the mechanisms. Vitamin D deficiency …
Clinically significant anticardiolipin antibodies associated with COVID-19
S Hossri, M Shadi, Z Hamarsha, R Schneider… - Journal of critical …, 2020 - Elsevier
The novel coronavirus strain known as SARS-CoV-2 has rapidly spread around the world
creating distinct challenges to the healthcare workforce. Coagulopathy contributing to …
creating distinct challenges to the healthcare workforce. Coagulopathy contributing to …